Table 2. Group A: patients in the COVID-19 era.

Group B: a control group of patients in the registry before the COVID-19 era.

Outcome data	Group A	Group B	P value
	(n: 30)	(n: 398)
Response to antimicrobials	17 (56.7%)	185 (46.5%)	0.28
Planned for surgery	14 (46.7%)	294 (73.9%)	0.001
Heart failure	9 (30%)	148 (37.2%)	0.431
Major arterial embolization	4 (13.3%)	133 (33.4%)	0.023
Neurologic events	3 (10%)	76 (19.1%)	0.216
Severe sepsis	7 (23.3%)	100 (25.1%)	0.827
AKI	12 (40%)	82 (20.6%)	0.013
Mortality	5 (16.7%)	108 (27.1%)	0.21

Notes.

AKI

acute kidney injury.

Data presented as frequency (percentage).